IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CAROSI, Giampiero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.004
AS - Asia 11.785
EU - Europa 9.132
SA - Sud America 2.350
Continente sconosciuto - Info sul continente non disponibili 440
AF - Africa 228
OC - Oceania 33
Totale 49.972
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.445
CN - Cina 4.284
SG - Singapore 3.841
UA - Ucraina 2.844
BR - Brasile 1.989
IT - Italia 1.535
HK - Hong Kong 1.407
DE - Germania 1.365
FI - Finlandia 752
VN - Vietnam 649
FR - Francia 575
GB - Regno Unito 540
TR - Turchia 464
RU - Federazione Russa 463
IE - Irlanda 446
IN - India 368
CA - Canada 259
BD - Bangladesh 240
SE - Svezia 167
PL - Polonia 139
MX - Messico 118
AR - Argentina 117
IQ - Iraq 73
EC - Ecuador 66
ZA - Sudafrica 63
PK - Pakistan 61
ID - Indonesia 57
BE - Belgio 53
CO - Colombia 51
NL - Olanda 48
JP - Giappone 44
VE - Venezuela 41
ES - Italia 39
SA - Arabia Saudita 39
AT - Austria 36
IL - Israele 36
UZ - Uzbekistan 36
MA - Marocco 35
JM - Giamaica 33
AU - Australia 31
AE - Emirati Arabi Uniti 27
CR - Costa Rica 26
KE - Kenya 24
CL - Cile 23
MU - Mauritius 23
IR - Iran 22
LT - Lituania 21
PY - Paraguay 21
EU - Europa 20
TT - Trinidad e Tobago 20
CZ - Repubblica Ceca 19
MY - Malesia 19
HN - Honduras 18
UY - Uruguay 17
EG - Egitto 16
GT - Guatemala 14
JO - Giordania 14
NG - Nigeria 14
PE - Perù 14
NI - Nicaragua 13
AZ - Azerbaigian 11
SV - El Salvador 11
DZ - Algeria 10
PR - Porto Rico 10
BB - Barbados 9
OM - Oman 9
PH - Filippine 9
PT - Portogallo 9
TN - Tunisia 9
BF - Burkina Faso 8
BO - Bolivia 8
AL - Albania 7
CW - ???statistics.table.value.countryCode.CW??? 7
DK - Danimarca 7
QA - Qatar 7
RS - Serbia 7
CH - Svizzera 6
DO - Repubblica Dominicana 6
GP - Guadalupe 6
KG - Kirghizistan 6
KZ - Kazakistan 6
LB - Libano 6
PA - Panama 6
RO - Romania 6
SC - Seychelles 6
TH - Thailandia 6
AM - Armenia 5
BG - Bulgaria 5
BH - Bahrain 5
EE - Estonia 5
GR - Grecia 5
HU - Ungheria 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
BS - Bahamas 4
ET - Etiopia 4
HR - Croazia 4
KR - Corea 4
LK - Sri Lanka 4
LV - Lettonia 4
Totale 49.496
Salva come PNG Salva come JPEG
Città #
Ashburn 2.316
Woodbridge 2.190
Fairfield 2.160
Jacksonville 2.087
Singapore 2.020
Hong Kong 1.405
Houston 1.210
Wilmington 1.146
San Jose 1.141
Council Bluffs 1.030
Ann Arbor 1.023
Cambridge 951
Chandler 945
Nanjing 839
Princeton 815
Seattle 811
The Dalles 769
Beijing 615
Columbus 444
Dublin 443
New York 442
Istanbul 360
Lauterbourg 358
Los Angeles 327
Helsinki 309
Nanchang 290
Ho Chi Minh City 239
São Paulo 233
Buffalo 228
Des Moines 206
Shenyang 200
Moscow 189
Hebei 175
Changsha 174
Milan 169
San Diego 149
Tianjin 141
Warsaw 133
Jiaxing 131
Jinan 130
Dearborn 119
Hanoi 118
Santa Clara 115
Dallas 111
Munich 104
Chicago 100
Kunming 97
Toronto 97
Shanghai 96
San Francisco 89
Hangzhou 83
Verona 81
Phoenix 77
Rome 72
Lancaster 64
Redondo Beach 64
Rio de Janeiro 59
Brescia 58
Kocaeli 56
Orem 55
Zhengzhou 55
Brussels 51
Atlanta 49
London 49
Guangzhou 47
Lanzhou 47
Mexico City 46
Montreal 46
Brooklyn 45
Nuremberg 44
Frankfurt am Main 42
Ningbo 41
Tokyo 41
Boardman 40
Turku 38
Belo Horizonte 36
Tashkent 35
Washington 33
Denver 32
Taizhou 32
Curitiba 30
Johannesburg 30
Charlotte 29
Leawood 28
Manchester 28
Campinas 27
Da Nang 27
Naples 27
Stockholm 27
Brasília 26
Porto Alegre 26
Norwalk 25
Baghdad 24
Chennai 24
Haikou 24
Haiphong 24
Pune 24
Biên Hòa 23
Guarulhos 23
Guayaquil 22
Totale 32.025
Salva come PNG Salva come JPEG
Nome #
Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA 267
Cos’è la Medicina Tropicale 258
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 239
The evolving burden of HIV infection compared with other chronic diseases in northern Italy 218
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 213
Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons 212
Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection 211
Hepatitis C infection influence on immune recovery in HIV-positive patients on successful HAART: The role of genotype 3 203
Long-term benefit of genotypic-guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patients 201
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy 193
HIV-associated asymmetric lipodystrophy syndrome 192
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients. 190
Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART. 189
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy. 188
A population-based database to study malignancies in HIV-infected patients in the Local Health Unit of Brescia (Northern Italy), period 1999-2009 187
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 187
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction 186
Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis 186
Trigger-oriented HIV testing at Internal Medicine hospital Departments in Northern Italy: an observational study (Fo.C.S. Study) 179
Bcl-2 expression is moderately correlated with long-term variability of CD4+ T-cell increase under successful highly active antiretroviral therapy 179
A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients. 178
Decrease of HCVRNA after three days of daily interferon treatment is predictive of the virological response at one month 178
Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications. 178
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. 177
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 177
Malaria and anaemia in pregnant women in urban Zanzibar, Tanzania. 176
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting 176
Caratteri generali dei protozoi patogeni per l’uomo e delle infezioni protozoarie umane 175
Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy 175
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 175
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naive for lopinavir with limited exposure to previous protease inhibitors. 175
Pilot dose-finding trial on interferon alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients not responding to interferon alone 174
Interleukin-2 therapy in patients with HIV infection 173
Accidental and transfusion malaria in Italy 171
Successful long-course after failure of short-course desensitization in a patient with severe hypersensitivity reaction to enfuvirtide 171
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients. 171
Il panorama internazionale dell’epidemia : il rischio di AIDS nel Viaggiatore Internazionale 170
Key Questions in antiretroviral therapy: Italian Consensus Workshop (2005) 168
Access site-related infection in dialysis: the AStRID project: a multicenter prospective Italian study. 167
HYALURONIC ACID AND LIVER STIFFNESS REDUCTION IN HIV-HEPATITIS-C (HCV) COINFECTED PATIENTS TREATED WITH A CCR5 INHIBITOR MARAVIROC (MVC) IN A RANDOMIZED CONTROLLED TRIAL (MAICOL STUDY-48-WEEK ANALYSIS) 166
Long-Term Response in Patients Receiving Haart Including Nelfinavir: Experience from Two Italian Centers 165
Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network 165
Access to antiretroviral therapy and disease progression in HIV+ migrants in Brescia, Italy 165
Hepatitis B virus and HIV coinfection in low-income countries: unmet needs. 165
STI epidemics in the Indian Ocean Region: can the phase be assessed? 164
Filariasis in travelers presenting to the Geosentinel Surveillance Network 164
HIV-1 genotype resistance pattern and evolution in patients failing nelfinavir containing regimens 163
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations 163
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study. 163
Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment 163
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 163
Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a. 161
Analisi estensiva di sequenza dei geni della trascrittasi inversa e della proteasi di HIV-1 in una coorte clinica di pazienti HIV positivi NAIVE per la terapia antiretrovirale. 160
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. 159
Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and Human Immunodeficiency Virus. 159
Adherence to surgical site infection guidelines in Italian cardiac surgery units. 159
The predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study 159
Modifications in SENV DNA detection and/or SENV subtype determination over a prospective follow-up in a cohort of HIV-positive patients: is this a moving target? 158
Recent increase in enterococci, viridans streptococci, Pseudomonas spp. and multiresistant strains among haematological patients, with a negative impact on outcome. Results of a 3-year surveillance study at a single institution. 158
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up. 158
VAGINAL COLONIZATION WITH CANDIDA SPP IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN: A COHORT STUDY 157
Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis. 157
A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis 157
CD4+ T cell evolution and predictors of its trend before and aftertenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load 157
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies 156
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin. 155
Fatal disseminated toxoplasmosis during primary HIV infection. 155
Characteristics of schistosomiasis in travelers reported to the GeoSentinel Surveillance Network 1997-2008 154
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients. 153
Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008 153
High prevalence of peripheral neuropathy in hepatitis C virus infected patients with symptomatic and asymptomatic cryoglobulinaemia 153
Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART 152
HIV-related liver disease: ARV drugs, coinfection, and other risk factors. 151
Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006 150
High prevalence of radiological vertebral fractures in HIV-infected males 150
Clinical presentation and outcome of hepatocellular carcinoma in HIV infected patients. 149
PHARMACOKINETIC-PHARMACODYNAMIC ASPECT OF ANTIMICROBIAL PROPHYLAXIS WITH TEICOPLANIN IN PATIENTS UNDERGOING MAJOR VASCULAR SURGERY. 149
Potential role of SEN virus on liver enzyme abnormalities in patients positive for hepatitis C virus with or without HIV infection. 149
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina 149
Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals. 149
HIV-1 resistance to dideoxynucleoside reverse transcriptase inhibitors: genotypic-phenotypic correlations 149
Baggage Malaria in Italy: Cryptic Malaria explained? 148
Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitors. 148
Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of Foscarnet versus Ganciclovir. 148
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis 147
Mortality for liver disease in patients with HIV infection: a cohort study 146
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial 146
Sex and gender differences in travel-associated disease 146
Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma 146
Animal-associated exposure to rabies virus among travelers, 1997–2012 146
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48 week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial 145
Malaria and HIV in adults: When the parasite runs into the virus 145
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy 144
Gastrointestinal Infection Among International Travelers Globally 143
Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients. 143
HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital 143
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study 143
Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART) 143
I data-base clinici e la sorveglianza degli eventi avversi: il progetto MASTER 142
Antiretroviral genotyping resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 142
Totale 16.741
Salva come PNG Salva come JPEG
Categoria #
all - tutte 237.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 237.661
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.969 0 0 0 0 31 170 94 190 168 433 282 601
2022/20232.769 457 24 31 232 268 820 3 272 424 25 86 127
2023/20242.154 138 68 128 149 82 370 57 53 663 23 17 406
2024/20255.883 26 18 28 594 866 515 679 186 620 362 1.212 777
2025/202610.901 1.085 1.626 850 1.711 850 694 1.722 430 654 803 309 167
2026/20274.609 632 640 1.240 1.860 237 0 0 0 0 0 0 0
Totale 49.972